Skip to main content

Table 5 Diagnostic performance of preoperative MR features and clinical indicators for predicting objective response of TACE

From: Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features

 

AUROC

95% CI

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Pretreatment PLT count

0.606

0.501–0.711

50.0

70.9

63.6

58.2

Number of nodules

0.613

0.508–0.718

58.9

63.6

62.3

60.3

Irregular margin

0.640

0.537–0.744

57.1

70.9

66.7

61.9

Clinical combined model

0.755

0.663–0.846

78.6

69.1

72.1

76.0

  1. TACE, transcatheter arterial chemoembolization; AUROC, the area under the receiver operating characteristic; PPV, positive predictive value; NPV, negative predictive value; CI, confidence interval; PLT, platelet